CSG & AWS Expand Collaboration to Accelerate Cloud Transformation in Telecommunications & Financial Services
New initiative reduces total cost of ownership by up to 60% and boosts cloud migration for global enterprises
In arapidly evolving digital economy, telecommunications and financial services companies face mounting pressure to modernise, scale operations and unlock innovation—all while managing costs and navigating complex growth journeys. Today,CSG® (NASDAQ: CSGS) announced a new strategic collaboration agreement with Amazon Web Services (AWS) to fast-track cloud transformation across these industries. The initiative will come to life through advanced cloud-native technologies, cost optimisation and platform innovation.
“As industries double down on cloud transformation, they need scalable, cost-efficient platforms that can evolve with them,” said Mayoor Mahendra, Vice President, Network Solutions, CSG. “Our extended collaboration with AWS amplifies the value of CSG’s Converged Mediation solution by pairing it with AWS’s global infrastructure. Together, we’re helping telco and banking and financial services leaders modernise faster, reduce costs and innovate with confidence.”
Building on a long-standing collaboration, this initiative brings CSG’s enhanced mediation capabilities to the AWS Marketplace. The solution delivers up to 60% total cost of ownership savings and accelerates customers’ journey to the cloud while unlocking new operational efficiencies. CSG and AWS will co-invest to expand access to cloud-native capabilities through technical enablement, go-to-market collaboration and ongoing platform innovation. In turn, CSG customers gain access to advanced technologies like AI, Agentic AI and GenAI—empowering them to scale efficiently, monetise investments and deliver differentiated experiences that build trust and long-term loyalty.
“AWS, along with CSG, is committed to helping our CSP customers advance in their digital transformation journey,” said Michael Singer, Director of North America Telecommunications, AWS. “This collaboration underscores our shared vision to help global enterprises modernise with a cloud-native approach, improve business outcomes with GenAI and deliver enhanced customer experiences.”
CSG and AWS will jointly present the benefits of the enhanced collaboration at the upcoming TM Forum DTW Ignite 2025 in Copenhagen. Stop by the CSG booth (#310) to learn more.
About CSG
CSG empowers companies to build unforgettable experiences, making it easier for people and businesses to connect with, use and pay for the services they value most. Our customer experience, billing and payments solutions help companies of any size make money and make a difference. With our SaaS solutions, company leaders can take control of their future and tap into guidance along the way from our fiercely committed and forward-thinking CSGers around the world.
Want to be future-ready and a change-maker like the global brands that trust CSG? Visit csgi.com to learn more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250616834947/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ASISA Partners with HCLTech to Drive Digital Transformation and Expansion in Iberia17.6.2025 13:41:00 CEST | Press release
HCLTech, a leading global technology company, has been selected by ASISA, a prominent health insurance provider in Spain, as its strategic IT partner to accelerate business transformation and expansion in Iberia. This partnership aims to accelerate ASISA's digital transformation journey to enhance the experience for its 2.2 million customers and position the company at the forefront of innovation in the region. HCLTech will modernize ASISA's IT platforms and leverage AI-based solutions to enhance business efficiency. The comprehensive mainframe modernization and solutions from HCLTech will enable ASISA to create a more agile, responsive IT infrastructure. “Partnering with HCLTech marks a key step in our digital transformation journey. By modernizing our platforms and embracing cutting-edge technologies, we are reinforcing our commitment to delivering exceptional service to our customers,” said José Pereira, CTO at ASISA. “This collaboration will empower ASISA with a more agile, scalabl
Biocytogen Responds to Harbour BioMed’s Patent Claims: RenNano® is an Independently Developed Platform with Distinct Innovation and Full Legal Standing17.6.2025 13:00:00 CEST | Press release
In response to Harbour BioMed’s recent press release regarding a procedural development in their ongoing legal claim, Biocytogen issues the following statement: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617098086/en/ Figure 1. Biocytogen’s RenNano® Platform Genetic Engineering Strategy (Source: https://biocytogen.com/antibody-drug-development/rennano） Biocytogen stands by its core values of independent innovation, respect for intellectual property, and a commitment to fair competition. The RenNano® platform is the result of independent, original R&D, based on Biocytogen’s proprietary genome editing technologies. Its technical principles, design strategy, and IP scope are fundamentally different from the patents in dispute. 120 vs. 9 – A Significant Technical Divide of RenNano® Platform; Biocytogen Will Resolutely Take Legal Actions to Protect Its Rights The RenNano® platform employs a large-fragment knock-in strategy
EDB Postgres® AI Accelerates New Era of Sovereign Data and AI for Enterprises, Industries, and Nations17.6.2025 13:00:00 CEST | Press release
The first secure Postgres platform that unifies transactional, analytical, and AI—democratizing agentic AI across hybrid environments through an easy-to-use interface EDB introduces new capabilities to the industry’s first Postgres-based data and AI platform, allowing enterprises to easily manage, observe, and democratize the use of agentic AI within a sovereign setting. Only 13% of enterprises globally have successfully deployed a broad set of agentic AI applications at scale, according to EDB research (May 2025). These early leaders are seeing dramatically better returns—up to 227% higher ROI than the remaining 87%, and 23% better ROI than the next-best group—so this launch is essential for businesses who want to come out on top in the AI race. EDB Postgres AI transforms core operational data into an AI-ready asset, with just five lines of code to set up an AI pipeline that automatically syncs embeddings with source data, taking AI from concept to production 3x faster while cutting c
G42 and Liquid AI Partner to Deliver Private, Local and Efficient AI Solutions to Enterprises at Scale17.6.2025 12:00:00 CEST | Press release
G42, the Abu Dhabi-based global technology group, and Liquid AI, a leading efficient foundation models company headquartered in Cambridge, Massachusetts, today announced that they have entered into a multifaceted commercial partnership to facilitate the creation, training and commercialization of generative AI solutions powered by Liquid Foundation Models. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617744482/en/ The goal of the partnership is to jointly develop and deploy private generative AI solutions internationally, from the Middle East and North Africa to the Global South, and across many sectors, such as investment and banking, consumer electronics, telecommunications, biotech, and energy. G42 companies such as Core42 and Inception are involved in various aspects of the partnership, from AI infrastructure for AI development to co-designing multimodal foundation models and deployment. “This partnership reflects o
Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)17.6.2025 10:28:00 CEST | Press release
Ferrer, a B Corp-certified international pharmaceutical company, has announced that FNP-223, a novel therapy in-licensed from Asceneuron and aimed at slowing the development of progressive supranuclear palsy (PSP), has received Fast Track designation from the US Food & Drug Administration (FDA). FNP-223, a new molecular entity in active development for PSP, is in an ongoing Phase 2 study to evaluate its safety, efficacy, and pharmacokinetics in adult patients with possible or probable PSP-Richardson syndrome (PSP-RS), the most common clinical variant of this neurodegenerative disease1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617437460/en/ Ferrer's pharmaceutical production plant in Sant Cugat del Vallés, Barcelona, Spain. “We are thrilled to receive Fast Track designation from the FDA for FNP-223 in the treatment of PSP. Consistent with our purpose of using business to fight for social justice, we are committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom